TUXEDO-4: phase II study of trastuzumab-deruxtecan in HER2-low breast cancer with new or progressing brain metastases

Colaboración

Año: 2025

Marhold, M; Batista, MV; Blancas, I; Morales, C; Saura-Manich, C; Saavedra, C; Ruíz-Borrego, M; Cortez, P; Slebe, F; Campolier, M; Santos, JC; Guerrero-Martínez, JA; Jiménez-Cortegana, C; Rottenmanner, B; Forstner, H; Bartsch, R; Preusser, M

Título: FUTURE ONCOLOGY

• Q3